A patient who has had a stroke does not have to have another one. The challenge for physicians is getting that patient to take the medications prescribed. A UK study defines the barriers to compliance.
As the treatment of relapsing remitting multiple sclerosis continues to add new treatment methods patients with progressive forms of the condition are still waiting for their first approved medication to manage their symptoms.
Acknowledging that uncertainty is a key factor in the care and treatment of multiple sclerosis is part of a solution to a problem, finding the best way to deal with that uncertainty is another issue that must be confronted by patients and doctors alike.
From the time a patient is diagnosed with multiple sclerosis there are often more questions than answers for extended periods of time. What that means for their care and management of symptoms is the subject of a recent study.
With a lot of the attention in multiple sclerosis care turning to finding treatments for progressive forms of the disease those who suffer relapses are in some ways being left in the shadows of treatment discoveries and care.
A recently concluded survey looked at issues most affecting patients with multiple sclerosis that they may not have been willing or able to discuss with health care providers but could help others with the condition in the future.